The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
- Discovery and validation of biomarkers for cancer detection, diagnosis and prognosis
- Novel assays, instrumentation and analysis algorithm for cancer screening, and metastasis and survival prediction
- Basic, pre-clinical and clinical testing for tumor genetic and epigenetic variations
- Development and evaluation of cancer immunotherapeutic strategies in preclinical models, and translational studies leading to pilot and/or phase-1 clinical trials
Shared Interests and Overlaps